Skip to content
PaperFren

Transient reprogramming rejuvenates fibroblasts ~30 years

Open paper intelligence

Maturation-phase transient OSKM expression (MPTR) rewinds transcriptome and epigenome aging clocks by ~30 years while cells reacquire fibroblast identity and youthful collagen/migration traits.

Source

Multi-omic rejuvenation of human cells by maturation phase transient reprogramming

Gill D, Parry A, Santos F, et al. · eLife · 2022

doi.org/10.7554/elife.71624Read the full paper ↗139 citationscc by

Inspect source passages

Transient reprogramming rejuvenates fibroblasts ~30 years

These passages occur verbatim in the stored paper text. They support the points listed below; they do not verify every statement in the explanation.

Transcriptome rejuvenated by ~30 years

our method substantially rejuvenated multiple cellular attributes including the transcriptome, which was rejuvenated by around 30 years as measured by a novel transcriptome clock.

Three middle-aged donors aged 38, 53, and 53 years

fibroblasts from three middle-aged donors (chronologically aged 38, 53, and 53 years old and epigenetically aged 45, 49, and 55 years old, according to the multi-tissue epigenetic clock Horvath, 2013 )
Read passages in the original paper

What they did

Gill et al. developed MPTR: express Yamanaka factors until maturation-phase rejuvenation, then withdraw. Applied to dermal fibroblasts from three middle-aged donors (ages 38/53/53), targeting the day 10–17 window suggested by clock trajectories, then measured transcriptome clocks, DNA methylation clocks, H3K9me3, collagen, and migration.

What they found

Cells temporarily lose then regain fibroblast identity (enhancer memory). Transcriptome rejuvenated ~30 years; epigenome similarly (H3K9me3; methylation clock). Effects exceeded prior transient protocols. Fibroblasts produced youthful collagen and partially recovered migration speed—showing rejuvenation can be separated from full pluripotency.

The limits

What it doesn't show

In vitro fibroblast results may not translate to safe in vivo rejuvenation. Donor n=3 is small; long-term genomic stability/tumor risk not fully settled.

Key terms

MPTR
Maturation phase transient reprogramming—OSKM until rejuvenation point, then withdrawal.
Yamanaka factors (OSKM)
Oct4, Sox2, Klf4, c-Myc reprogramming cocktail.
Aging clock
Transcriptomic/epigenetic predictor of biological age.
H3K9me3
Heterochromatin-associated histone mark assessed for rejuvenation.
Epigenetic memory
Enhancer/persistent programs enabling regain of fibroblast identity.
Maturation phase
Mid-reprogramming stage where epigenome rejuvenation emerges before pluripotency.

Flashcards

1 / 8

0 of 8 answers reviewed

Research intelligence for this paper

See its role on concept claims, tensions it is part of, placement history, and related discoveries.

Open paper intelligence

Quiz yourself

1 / 5

MPTR stands for…

Common questions

What is MPTR?

Transient OSKM expression through maturation phase, then withdrawal before full reprogramming.

How much transcriptome rejuvenation?

Around 30 years by a novel transcriptome clock.

Do cells stay fibroblasts?

They temporarily lose then reacquire fibroblast identity.

Any functional gains?

Youthful collagen protein levels and partial migration-speed rejuvenation.

More on Epigenetics